Evotec (OTCMKTS:EVTCY) Reaches New 1-Year Low at $3.64

Evotec SE (OTCMKTS:EVTCY)’s share price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $3.64 and last traded at $3.84, with a volume of 236874 shares traded. The stock had previously closed at $4.33.

Evotec Trading Down 11.3 %

The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57. The business has a fifty day simple moving average of $4.75 and a 200 day simple moving average of $6.13. The stock has a market cap of $1.27 billion, a price-to-earnings ratio of 10.56 and a beta of 0.98.

Evotec Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.